> top > docs > PMC:7205724 > spans > 21785-21983 > annotations

PMC:7205724 / 21785-21983 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
740 16-20 Gene denotes ACE2 Gene:59272
750 99-102 Gene denotes IL6 Gene:3569
751 117-135 Disease denotes hyper inflammation MESH:D007249
762 136-147 Chemical denotes Tocilizumab MESH:C502936

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T159 55-64 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T164 123-135 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T260 85-86 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T261 177-178 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T262 179-188 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes humanized

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T176 23-64 Sentence denotes 6.2 Targeting pro-inflammatory cytokines
T177 66-84 Sentence denotes 6.2.1 Hypothesis:
T178 85-135 Sentence denotes A mAb against IL6 can attenuate hyper inflammation

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
740 16-20 Gene denotes ACE2 Gene:59272
750 99-102 Gene denotes IL6 Gene:3569
751 117-135 Disease denotes hyper inflammation MESH:D007249
762 136-147 Chemical denotes Tocilizumab MESH:C502936

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T2073 99-102 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T37015 1-4 IN denotes for
T86465 5-12 VBG denotes binding
T1893 13-15 TO denotes to
T91196 16-20 NN denotes ACE2
T54390 23-26 CD denotes 6.2
T7377 28-37 VBG denotes Targeting
T2754 38-54 JJ denotes pro-inflammatory
T79617 55-64 NNS denotes cytokines
T42975 66-71 CD denotes 6.2.1
T96891 73-83 NN denotes Hypothesis
T41163 83-84 -COLON- denotes :
T35174 85-86 DT denotes A
T74401 87-90 NN denotes mAb
T75556 91-98 IN denotes against
T83617 99-102 NN denotes IL6
T67953 103-106 MD denotes can
T68840 107-116 VB denotes attenuate
T2426 117-122 NN denotes hyper
T92661 123-135 NN denotes inflammation
T86439 136-147 NNP denotes Tocilizumab
T21494 147-148 -COMMA- denotes ,
T50157 149-153 RB denotes also
T26283 154-159 VBN denotes known
T43571 160-162 IN denotes as
T44785 163-172 NN denotes atlizumab
T96810 172-173 -COMMA- denotes ,
T58761 174-176 VBZ denotes is
T56416 177-178 DT denotes a
T79548 179-188 JJ denotes humanized
R67300 T86465 T37015 arg2Of binding,for
R53767 T86465 T1893 arg1Of binding,to
R3636 T91196 T1893 arg2Of ACE2,to
R75716 T54390 T7377 arg1Of 6.2,Targeting
R93465 T79617 T7377 arg2Of cytokines,Targeting
R69719 T79617 T2754 arg1Of cytokines,pro-inflammatory
R92270 T96891 T42975 arg1Of Hypothesis,6.2.1
R64820 T96891 T41163 arg1Of Hypothesis,:
R32577 T74401 T41163 arg2Of mAb,:
R79527 T74401 T35174 arg1Of mAb,A
R58839 T74401 T75556 arg1Of mAb,against
R72696 T83617 T75556 arg2Of IL6,against
R84073 T96891 T67953 arg1Of Hypothesis,can
R74784 T68840 T67953 arg2Of attenuate,can
R14765 T96891 T68840 arg1Of Hypothesis,attenuate
R94556 T92661 T68840 arg2Of inflammation,attenuate
R98822 T92661 T2426 arg1Of inflammation,hyper
R83125 T86439 T21494 arg1Of Tocilizumab,","
R13146 T26283 T50157 arg1Of known,also
R82868 T86439 T26283 arg2Of Tocilizumab,known
R76811 T26283 T43571 arg1Of known,as
R6462 T44785 T43571 arg2Of atlizumab,as
R65301 T58761 T96810 arg1Of is,","
R91756 T86439 T58761 arg1Of Tocilizumab,is

LitCovid-sample-PD-GO-BP-0

Id Subject Object Predicate Lexical cue
T31 123-135 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T159 55-64 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T159 123-135 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166

LitCovid-sample-GO-BP

Id Subject Object Predicate Lexical cue
T27 123-135 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T27 123-135 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T176 23-64 Sentence denotes 6.2 Targeting pro-inflammatory cytokines
T177 66-84 Sentence denotes 6.2.1 Hypothesis:
T178 85-135 Sentence denotes A mAb against IL6 can attenuate hyper inflammation